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Magnetic resonance (MR) reporter genes have the potential for tracking the biodistribution and fate of cells in vivo,
thus allowing the safety, efficacy and mechanisms of action of cell-based therapies to be comprehensively assessed.
In this study, we evaluate the effectiveness of the iron importer transferrin receptor-1 (TfR1) as an MR reporter gene
in the model cell line CHO-K1. Overexpression of the TfR1 transgene led to a reduction in the levels of endogenous
TfR1 mRNA, but to a 60-fold increase in total TfR1 protein levels. Although the mRNA levels of ferritin heavy chain-1
(Fth1) did not change, Fth1 protein levels increased 13-fold. The concentration of intracellular iron increased signif-
icantly, even when cells were cultured in medium that was not supplemented with iron and the amount of iron in the
extracellular environment was thus at physiological levels. However, we found that, by supplementing the cell cul-
ture medium with ferric citrate, a comparable degree of iron uptake and MR contrast could be achieved in control
cells that did not express the TfR1 transgene. Sufficient MR contrast to enable the cells to be detected in vivo follow-
ing their administration into the midbrain of chick embryos was obtained irrespective of the reporter gene. We con-
clude that TfR1 is not an effective reporter and that, to track the biodistribution of cells with MR imaging in the short
term, it is sufficient to simply culture cells in the presence of ferric citrate. Copyright © 2016 The Authors Contrast
Media & Molecular Imaging Published by John Wiley & Sons Ltd.
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1. INTRODUCTION
Cell-based therapies have enormous potential to treat conditions
that are refractory to other forms of therapy, including various
degenerative diseases and cancer (1). The efficacy of cell-based
therapies has already been demonstrated in numerous preclini-
cal studies, but lack of knowledge pertaining to the biodis-
tribution and fate of the cells poses a major safety concern,
and is an important issue preventing the translation of these
promising therapies to the clinic (2). The imaging modalities that
can be used to track the biodistribution and fate of administered
cells in vivo include bioluminescence, fluorescence, photoacoustic,
nuclear and magnetic resonance (MR) imaging (3). Although all of
these modalities can be used to image cells in small animals, only
nuclear and MR imaging have the penetration depth required to
image cells within the internal organs of humans. A drawback of
nuclear imaging techniques, however, is that they suffer frompoor
spatial resolution, and perhapsmore importantly require exposure
to ionizing radiation, which is particularly problematic for longitu-
dinal studies that necessitate repeated scanning. MR imaging
(MRI), on the other hand, which has very high spatial resolution
and an excellent safety profile, has already been used to success-
fully track labelled cells in animal models and in humans (4,5).
Most MRI-based cell tracking studies to date have focussed on
imaging cells labelled with MR contrast agents, such as super-
paramagnetic iron oxide nanoparticles (SPIONs) or fluorine-based
compounds (19F) (4,6). While these direct cell labelling approaches
can be very good for monitoring the biodistribution of cells in the
short term, they are not suitable for long-term cell tracking, the
main reasons being that (i) their concentration in the cell is diluted
by 50% with each cell division, which means that after several cell
divisions they may become undetectable (7), (ii) they can degrade
within the cell, (iii) if the labelled cell dies, the contrast agent can be
taken up by host cells, leading to false positive results (8,9) and (iv)
they can only be used for monitoring cellular biodistribution and
give no indication of cell phenotype or differentiation status. For
these reasons, there has been an increasing interest in exploring
the possibility of using MR reporter genes for cell tracking (10).
The advantage of reporter genes is that the intensity of their
signal is maintained with each cell division, and can rapidly dis-
appear if the cell dies, thereby facilitating the detection of viable
cells and avoiding the potential problem of detecting false
positives. Furthermore, reporter genes can be used for a more
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diverse set of applications depending on the promoter used to
drive their expression; for instance, constitutive promoters can
be used for biodistribution studies, whereas cell-type-specific
promoters can indicate the cell’s differentiation status.
A range of MR reporter genes have been proposed (10), but
the majority of the systems used to date are involved in the reg-
ulation of iron homeostasis. Overexpression of such reporters fa-
cilitates cell tracking by increasing the intracellular concentration
of iron to levels that are high enough to generate detectable MR
contrast. Mammalian MR reporters include the transferrin recep-
tor, which is required for importing iron into the cell (11,12), and
ferritin, which is required for iron storage (13,14). To ensure iron
homeostasis is maintained, the expression of the transferrin re-
ceptor and ferritin genes is tightly regulated at both the transcrip-
tional and translational levels (15). For instance, when intracellular
iron concentrations are low, expression levels of the transferrin re-
ceptor increase so that iron can be repleted through the import of
holo-transferrin (i.e. iron-bound transferrin) from the extracellular
environment. Concomitantly, levels of ferritin decrease so more
iron is released from ferritin iron stores into the labile iron pool
(LIP). When intracellular iron stores are high, the reverse events
happen; i.e., transferrin receptor expression decreases to reduce
levels of imported iron, and ferritin levels increase, so that the ex-
cess iron is safely stored within ferritin complexes (16).
We have recently investigated if overexpression of ferritin
heavy chain-1 (Fth1) and transferrin receptor-1 (TfR1) in mouse
mesenchymal stem cells (mMSCs) affects iron homeostasis and
cell phenotype (17). In that study, we reported that, at physiolog-
ical concentrations of extracellular iron (i.e. in the absence of
ferric citrate supplementation), overexpression of Fth1 reduced
proliferation and led to changes in cell phenotype, suggesting
that Fth1 might only be suitable for tracking cells in organs
and tissues where iron levels are sufficiently high to maintain
the cell’s viability. TfR1 overexpression, on the other hand, was
well tolerated by the mMSCs and did not cause any obvious ad-
verse effects on the cell’s phenotype. Unexpectedly, however,
overexpression of TfR1 did not increase intracellular iron levels
in mMSCs, making it an ineffective MR reporter in this cell type
(17). It is possible that the failure of TfR1 to operate as an MR re-
porter in mMSCs might have been because the expression levels
of the recombinant TfR1 protein were insufficient. Thus, to fur-
ther explore the potential of TfR1 as an MR reporter, in the cur-
rent study we have used a bicistronic TfR1:GFP lentiviral vector
to induce high levels of TfR1 expression in Chinese hamster
ovary (CHO) cells. CHO cells are known for their ability to express
high levels of recombinant protein (18), and thus present an
ideal test system for evaluating the TfR1 reporter. Using this
CHO reporter line, we have investigated the effect of TfR1 over-
expression on iron homeostasis in vitro, and evaluated the effec-
tiveness of TfR1 as an MR reporter in vivo using a 3Rs-compliant
chick embryo model.
2. RESULTS
2.1. Expression of a bicistronic TfR1:GFP reporter in
CHO-K1 cells
To enable TfR1 transgene expression to be monitored in CHO-K1
cells using flow cytometry and fluorescence imaging, mouse
TfR1 was cloned upstream of IRES-GFP under the control of the
Figure 1. Transduction efficiency of CHO-K1 is almost 100% with both GFP and TfR1:GFP lentiviral particles. (A) Flow cytometry analyses show success-
ful integration of the transgenes (histogram, fraction of positive cells and the green fluorescence intensity). (B) Phase contrast and fluorescence images
of CHO-K1 cells that were transduced with each of the constructs. Scale bars correspond to 100 μm.
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constitutive promoter EF-1α, as previously described (17). The
TfR1 iron response element was removed prior to cloning to en-
sure efficient translation of the TfR1 protein; this well-established
strategy allows circumvention of the negative feedback loop
that prevents the accumulation of TfR1 protein when the con-
centration of intracellular iron is high (19–22). Flow cytometry
showed that the transduction efficiency with both TfR1:GFP
and GFP control lentivirus was almost 100% (Fig. 1A). The fluo-
rescence intensity of the TfR1:GFP transduced cells was slightly
lower than that of the cells transduced with GFP alone, which
is probably due to the differences in construct size and the fact
that GFP is expressed downstream of IRES. Fluorescence micros-
copy confirmed the results obtained with flow cytometry (Fig. 1B).
2.2. Effect of TfR1 reporter expression on TfR1 and Fth1
mRNA and protein levels
RT-qPCR analysis confirmed robust expression of the mouse TfR1
reporter in CHO-K1 cells (Fig. 2A). Using specific primers to distin-
guish between mouse and hamster TfR1, RT-qPCR showed that
overexpression of mouse TfR1 caused a significant down-
regulation of endogenous TfR1 in the CHO-K1 cells (Fig. 2B). Nev-
ertheless, despite the reduced levels of endogenous TfR1 mRNA,
overexpression of the mouse transgene resulted in an approxi-
mately 60-fold increase in TfR1 total protein levels (Fig. 2C, F).
Although overexpression of TfR1 did not affect Fth1 mRNA levels
(Fig. 2D), an approximately 13-fold increase in Fth1 protein levels
was observed (Fig. 2E, F).
2.3. Effect of TfR1 reporter expression on intracellular iron
content
The ability of the TfR1 reporter to increase the intracellular iron
content of CHO-K1 cells was investigated under conditions
where the concentration of extracellular iron was increased by
supplementation with 0 mM (control), 0.2 mM or 2 mM ferric cit-
rate (FC), the maximum concentration of FC that the cells toler-
ated without displaying any toxic effects (Fig. 3). The latter two
conditions were additionally supplemented with 50 μM ascorbic
acid and 1.28 mM human holo-transferrin, as previously de-
scribed (17), which allows maximum intracellular iron accumula-
tion (Fig. S2). The basal medium used here contains only
approximately 250 nM of iron. In the absence of FC supplemen-
tation, cells displayed an intracellular iron content of about 0.01
pg/cell, which significantly increased to about 0.03 pg/cell when
expressing TfR1 (Fig. 4A). Likewise, in the presence of 0.2 mM FC,
the iron content of TfR1+ cells was significantly higher than that
of controls (0.09 pg/cell compared with 0.05 pg/cell). Although a
further increase in the iron content of the TfR1+ cells was ob-
served in the presence of 2 mM FC, it was not significantly
Figure 2. Overexpression of TfR1 transgene leads to a significant down-regulation of endogenous TfR1mRNA and a dramatic increase in levels of TfR1
and ferritin protein. Relative quantification of (A) exogenous TfR1 transcripts, (B) endogenous TfR1 transcripts, (C) total TfR1 protein, (D) Fth1 transcripts
and (E) Fth1 protein. (F) Representative western blot. Error bars represent SEM (n = 3).
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different from controls (~0.22 pg/cell compared with 0.11
pg/cell) (Fig. 4A). Differences in iron content were reflected in
the T2 relaxation time of the cell pellets, which was reduced with
respect to controls for cells expressing the TfR1 reporter, when
cultured in the absence of FC supplementation or in the pres-
ence of 0.2 mM FC (Fig. 4B). Of note, although these results show
that the TfR1 reporter can effectively increase the intracellular
iron content of CHO-K1 cells, the observed increase was quite
modest, and a much greater increase in iron content and reduc-
tion in relaxation time could be achieved by simply
supplementing the culture medium with FC; for instance, in the
presence of 2 mM FC, the iron content of untransduced CHO-
K1 cells increased from about 0.01 to 0.11 pg/cell (Fig. 4A) and
was associated with a substantial reduction in transverse relaxa-
tion time (Fig. 4B).
2.4. MRI
To evaluate the effectiveness of both the TfR1 reporter and extra-
cellular iron supplementation for facilitating MRI-based cell
tracking, CHO-K1 cells transduced with the GFP construct (con-
trols) or the bicistronic TfR1:GFP reporter were injected into the
midbrain of chick embryos in ovo at Embryonic Day 3 (E3). Both
cell types were cultured in the presence of 0 mM, 0.2 mM or
2 mM FC for 3 days prior to injection. At E5, embryos were im-
aged using fluorescence microscopy to identify the location of
the transplanted GFP+ cells. MRI was then performed to see if
overexpression of the TfR1 reporter and/or FC supplementation
enabled these same cells to be visualized with both the fluores-
cence and MR imaging modalities. As we have previously
shown (7,17) cells injected into a single site at E3 are often
found in the form of several clusters at E5 (Fig. 5), which is a
consequence of the quick brain development during this pe-
riod. These conditions offer the chance to monitor the migra-
tion of cells and, in combination with fluorescence imaging,
which enables the tracking of cell viability, ensure that any
MR contrast is not a result of the carryover of iron to a single
site or the accumulation of iron from dead cells. In all condi-
tions, it was possible to detect a loss in MR signal at the sites
where clusters of cells expressing either GFP or TfR1:GFP were
detected via fluorescence imaging (Fig. 5 and Fig S4). Although
it might appear surprising that GFP+ cells cultured in the ab-
sence of FC supplementation could be detected via MR, it is im-
portant to note that the T2 relaxation time of the chick
embryo’s brain is relatively long. Our own measurements and
previous reports (23) suggest relaxation times over 200 ms at
this embryonic stage and thus much longer than we have mea-
sured for GFP cell pellets cultured in the absence of FC (114 ms,
Fig. 4B). The loss of signal for clusters of cells expressing TfR1:
GFP appears to be stronger; however, a definite quantification
is not possible as the number of cells per cluster can vary.
When cells had been cultured in the presence of 0.2 mM FC,
hypointense regions corresponding to GFP or TfR1:GFP cell ag-
gregates could be easily identified via MR (Fig. 5), and similar
results were obtained in the presence of 2 mM FC (Supporting
Information). From these results, it appears that, in the presence
of FC supplementation, TfR1 overexpression in CHO-K1 cells
does not lead to any noticeable enhancement in MR detection
sensitivity in this model.
3. DISCUSSION
To evaluate the effectiveness of TfR1 as an MR reporter gene we
have generated a CHO-K1 cell line that expresses a bicistronic
TfR1:GFP reporter. Overexpression of the TfR1 transgene led to
a decrease in endogenous TfR1 mRNA levels. This was not unex-
pected because the 3′ untranslated region (UTR) of the endoge-
nous TfR1 mRNA contains five iron responsive elements (IREs),
Figure 3. The viability of CHO-K1 cells after exposure to ferric citrate.
Cells were exposed to FC for 24 h and the viability was quantified using
a colorimetric assay based on the water-soluble tetrazolium salt WST-8.
Viability is expressed as the absorbance at 450 nm in relation to control
(untreated) cells. Error bars represent the SD from three measurements
and the concentrations used as a supplementation for iron loading are
shown in red. A maximum supplementation of 2 mM FC, where viability
was above 90%, was chosen for all experiments.
Figure 4. The effect of TfR1 reporter on the (A) intracellular iron content
and (B) T2 relaxation of CHO-K1 cells. Control and transduced cells were
cultured for 72 h with regular medium or supplemented with ascorbic
acid, human holo-transferrin and ferric citrate at a concentration of 0.2
or 2 mM. Error bars represent the SEM (n = 3) for the intracellular iron
content and the pixel-based SD for the T2 relaxation. The relaxation data
(signal versus TE) are presented in Fig. S3.
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Figure 5. Fluorescence and MR imaging of cells implanted into the brain of a chick embryo. Cells (2 × 105) expressing GFP or TfR1:GFP were implanted
into the midbrain of chick embryos at E3. At E5 the embryos were harvested from their eggs, imaged with a fluorescence stereomicroscope and fixed
prior to MRI using a T2-weighted RARE sequence. Clusters of cells expressing GFP were found in different regions of brain via fluorescence microscopy
and are indicated with arrows. These clusters could then be identified as hypointense regions in the MR images. Six sagittal slices through the chick are
shown in the right-hand panel. Scale bars represent 1 mm.
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which ensures that the mRNA is degraded when intracellular iron
concentrations are high (24–26). To prevent the TfR1 transgene
from being regulated by this negative feedback loop, we used the
previously described strategy of deleting the IREs from the 3′UTR,
which enables high levels of the exogenous TfR1mRNA to accumu-
late in the cells (11,19). Consequently, we were able to achieve a
more than 60-fold increase in TfR1 protein levels in the CHO-K1 cells.
Overexpression of TfR1 had no effect on Fth1mRNA levels, but
resulted in a 13-fold increase in Fth1 protein. It is well established
that, in response to increasing intracellular iron concentrations,
the binding activity of iron regulatory proteins to the IRE located
within the 5′UTR of ferritin mRNAs is reduced, promoting protein
translation (27). Therefore, the observed increase in Fth1 protein
in the CHO-K1 reporter line is most probably due to increased in-
tracellular iron concentrations resulting from the overexpression
of TfR1 leading to its storage within ferritin, which is ultimately
responsible for the generation of T2 contrast. However, a recent
study from our group showed that overexpression of TfR1 in
mMSCs did not lead to an increase in Fth1 protein levels (17).
This is probably because TfR1 protein increased by only 15-fold
in the mMSCs, compared with more than 60-fold in the CHO-
K1 cells. It is thus likely that, in the mMSCs, the concentration
of intracellular iron in the labile iron pool did not reach the
threshold required to increase the rate of Fth1 mRNA translation
above baseline levels. Interestingly, a recent paper has shown
that the concentration of intracellular iron required to trigger
ferritin expression, and hence iron storage, can vary between
different cell types (28), suggesting that for MRI detection some
cell types may require higher levels of TfR1 protein expression
than others.
In the absence of FC supplementation, overexpression of TfR1
in CHO-K1 cells led to a more than threefold increase in the
concentration of intracellular iron. When cultured in serum-
containing medium, cells obtain iron from holo-transferrin,
which is a constituent of the FCS used in standard cell culture
media (29). However, we have recently shown that, without FC
supplementation, overexpression of the same TfR1 transgene in
mMSCs did not increase the concentration of intracellular iron,
despite the fact that both cell types were cultured in the pres-
ence of 10% FCS. Likewise, an earlier study has shown that over-
expression of TfR1 in a mouse neural stem cell (mNSC) line did
not significantly increase intracellular iron concentrations in the
absence of FC supplementation (19). The ability of the CHO-K1
cells expressing the TfR1:GFP+ reporter to accumulate iron in
the absence of FC is probably due to the expression of very high
levels of the recombinant TfR1 protein. These observations are
important because they indicate that TfR1might not be an effec-
tive MR reporter for cell types that do not efficiently express re-
combinant proteins, for if the expression level of recombinant
TfR1 protein cannot be raised above a certain threshold it may
not be possible to increase the concentration of intracellular iron
above background levels (at least under physiological condi-
tions), rendering the cells undetectable with MRI.
In the presence of 0.2 mM FC, TfR1 overexpression in CHO-K1
cells led to an approximate twofold increase in intracellular iron.
However, this did not lead to any noticeable changes in MR con-
trast (T2 relaxation), which was probably because the increase
was very low and close to background levels. The increase in in-
tracellular iron in TfR1-expressing CHO-K1 cells is in contrast to
mMSCs, where under the same FC supplementation conditions
overexpression of TfR1 did not lead to any increase in intracellu-
lar iron levels (17). It is important to note that, for both cell types,
supplementing the culture medium with FC increased intracellu-
lar iron concentrations to a greater extent than did overexpress-
ing TfR1; for CHO-K1 cells supplementation with 0.2 mM and 2
mM FC led to a respective fivefold and 10-fold increase in intra-
cellular iron, and for mMSCs to a respective 10-fold and 40-fold
increase (17). This was also the case for mNSCs, where supple-
mentation with 1 mM FC led to an approximate 10-fold increase
in intracellular iron (19). Taken together, these data indicate that,
for all cell types tested to date, FC supplementation appears to
be a much more effective means of increasing intracellular iron
concentrations than does overexpressing TfR1, suggesting that
to track cells with MRI it might be sufficient to simply incubate
cells in the presence of FC shortly before implantation, rather
than undertaking the more involved procedure of genetically
manipulating the cells so that they overexpress TfR1. This is also
the case for the ferritin reporters, where, similarly to TfR1, overex-
pression does not always increase intracellular iron concentra-
tions as effectively as supplementation with FC (17,30–32).
However, such an approach would only be suitable for short-
term tracking, as it would be expected that with time the iron
load would return to baseline levels and the cells would no lon-
ger be detectable via MRI. A further point to consider is that the
concentration of intracellular iron appears to vary quite signifi-
cantly depending on cell type, in both the presence and absence
of FC (Table 1). For instance, the intracellular iron concentration
of mNSCs (19) is about an order of magnitude lower than that











hMSCs 0.08 0.25 0.34 4 39
CHO-K1 0.01 0.20 0.05 5 this study
mNSCs 0.002 1.0 0.02 10 19
mMSCs 0.02 0.20 0.23 10 17
mB16F10 0.15 0.20 1.90 13 31
rGlioma F98 0.25 0.50 3.50 14 30
mDCs 0.06 0.25 2.15 36 33
When exact values were not mentioned in the studies these were estimated from the charts presented.
*Some studies employ ferric ammonium citrate, the Mw of which is slightly higher than that of FC, as a supplement.
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observed with mMSCs (17), and when supplemented with FC
two orders of magnitude lower than that of supplemented
mouse dentritic cells (mDCs) (33). This suggests that some cell
types might be easier to detect with MRI due to their intrinsically
higher concentrations of intracellular iron or higher capacity to
accumulate iron when supplemented with FC.
Our in vivo imaging results showed that CHO-K1 can be
detected with MRI following injection into chick midbrain, even
when the cells have not been supplemented with FC. This was
probably related to the short relaxation time of the chick em-
bryo brain, which leads us to suggest that relaxometric proper-
ties of a tissue might have an impact on the detection
sensitivity of implanted cells. Our results contrast with previous
studies involving the tracking of mNSCs in the mouse brain,
where, in the absence of FC, cells were not detected in vivo
with a 7 T MR scanner irrespective of the presence of reporter
genes (19). This suggests that, in the absence of iron supple-
mentation, the intrinsic amount of iron present in mNSC cells
is not enough to produce contrast in the brain of mice, even
when using a reporter gene.
Although our results and those of others (19) indicate that
culturing cells in the presence of FC can generate sufficient con-
trast for MRI detection, this approach is unlikely to be as sensitive
as labelling cells with SPIONs. With SPION labelling, intracellular
iron concentrations of more than 5 pg/cell can easily be
achieved (7,34), and importantly the inherent superparamag-
netism of the SPIONs means that, in contrast to FC, MR detection
is not reliant on the availability of ferritin.
4. CONCLUSION
TfR1 has potential use as an MR reporter gene, but importantly
only if it is possible to achieve the high levels of expression re-
quired to significantly increase both the concentration of intra-
cellular iron and the levels of ferritin protein. In this study, we
have demonstrated the feasibility of using TfR1 as an MR re-
porter in CHO-K1 cells, but it should be noted that these cells
can be very efficiently transduced and tend to express high
levels of recombinant proteins. Before attempting to use TfR1
as a reporter gene in other cell types, it would be important
to consider (i) the ease with which the cells can be transduced,
(ii) their ability to express high levels of recombinant proteins
and (iii) the concentration of intracellular iron required to trig-
ger ferritin expression. To track cells with MRI in the short term,
simply loading cells with iron by supplementation with FC is
likely to be an easier and more effective strategy than overex-
pressing TfR1.
5. MATERIALS AND METHODS
5.1. Cell culture
Chinese hamster ovary (CHO) K1 cell line (CCL-61TM, ATCC,
Teddington, UK) was cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM) F12 containing 10% fetal calf serum (FCS) at 37 °C
under a humidified atmosphere with 5% CO2. Culture
plates/dishes were treated with 0.1% (w/v) gelatine solution at
room temperature for at least 15 min, prior to seeding. All culture
media and supplements were purchased from Sigma-Aldrich,
Gillingham, UK, unless stated otherwise.
5.2. Generation of lentiviral constructs and CHO-K1
transduction
Mouse TfR1 (NM_011638.4) cDNA was synthesized from an RNA
sample of murine MSC D1 cell line (CRL-12424™, ATCC,
Teddington, UK). Iron responsive elements were excluded from
amplification as previously described (17). TfR1 cDNA was cloned
into the pHIV-eGFP plasmid (21373, Addgene, Cambridge, MA,
USA). Viral production and titration methods were performed
as previously described (17,35). For CHO-K1 transduction with
lentiviral particles, cells (103 cells/well in a 48-well plate) were
transduced with a multiplicity of infection (MOI) of 100 for 16 h
in the presence of Polybrene (8 μg/mL). Transduction of cells
was performed in three independent experiments (n = 3). After
transduction, cells were allowed to expand for 7 days and then
subcultured every 3–5 days. Non-transduced cells were main-
tained at the same passage number.
5.3. Flow cytometry and fluorescence microscopy
Expression of GFP was evaluated via flow cytometry using a BD
FACSCalibur instrument (BD Biosciences, Oxford, UK), with a
488 nm excitation laser and FL1 detector, and via fluorescence
microscopy using a Leica DM IL inverted fluorescence micro-
scope coupled to a Leica DFC420C camera.
5.4. RT-qPCR and western blotting
For RT-qPCR, 9 × 104 cells were collected three passages after
transduction, and cDNA synthesis and RT-qPCR (CFX Connect™
real-time PCR detection system, Bio-Rad, Hemel Hempstead,
UK) were performed according to the manufacturer’s instruc-
tions (Fast SYBR® Green Cells-to-CT™ Kit, Life Technologies, Pais-
ley, UK). The polyadenylate-binding protein nuclear 1 (Pabpn1)
and the vezatin adherens junctions transmembrane protein
(Vezt) genes (36) were used as reference genes for data normal-
ization. Primers used for all transcripts are detailed in the
supporting information (Table S1). Data analysis was performed
using the CFX system test software (Bio-Rad), which applies the
ΔΔCt method to normalize gene expression. For western blot-
ting, 106 cells were collected at passage 8 after transduction.
All methodology and materials used for western blotting were
as previously described (17). Anti-ferritin heavy chain 1
(ab65080, Abcam, Cambridge, UK), anti-transferrin receptor 1
(ab84036, Abcam) and anti-actin (ab1801, Abcam) antibodies
were used as primary antibodies and IRDye 680RD donkey anti-
rabbit (926-68073, LI-COR, Cambridge, UK) as a secondary anti-
body. Total protein gels were used for data normalization and
actin was used as a reference to confirm data normalization.
5.5. Iron loading and quantification
To evaluate the concentrations of iron supplementation that
CHO-K1 cells tolerate, 5 × 103 cells were seeded in 96-well plates,
cultured for 24 h, and then exposed to increasing concentrations
of FC for 24 h. Viability was assessed using a Cell Counting Kit 8
(Sigma) according to the manufacturer’s instructions. To mea-
sure intracellular iron loading, cells (5 × 104 cells/well in a six-well
plate) were incubated for 4 days with ferric citrate (0.2 or 2 mM
depending on the experimental conditions), and additionally
50 μM L-ascorbic acid (37) and 1.28 mM human holo-transferrin.
Cells cultured in regular culture medium were used as controls.
Intracellular iron was quantified by digesting 106 cells in 100 μL
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0.6 M HCl/0.14 M KMnO4 for 2 h at 60 °C. The digested cells were
then reacted with 20 μL of ferrozine reagent (5 M ammonium ac-
etate, 2 M ascorbic acid, 6.5 mM 3-(2-pyridyl)-5,6-diphenyl-1,2,4-
triazine-p,p′-disulfonic acid monosodium salt hydrate and 15.4
mM neocuproine) for 30 min, leading to development of a
coloured complex. The absorbance of the solution was read at
570 nm and iron was quantified using a reference curve ob-
tained with an iron standard (TraceCERT™, Sigma) prepared un-
der the same conditions.
5.6. Cell pellet relaxation measurements
Cells (107) were cultured under the same conditions as described
for iron uptake. Cells were then fixed with 4% formaldehyde,
transferred to 0.2 mL polypropylene tubes and centrifuged for
30 min at 13 400 g. The supernatant was removed and 1%
low-melting agarose was used to cover the top of the cell pellet.
Sagittal MR images were acquired with a Bruker 9.4 T Avance III
HD instrument (Bruker, Coventry, UK) with a 40 mm transmit–
receive quadrature volume coil using a multi slice multi echo
(MSME) spin echo sequence with 25 echoes, an inter-echo time
of 8 ms and repetition time of 3577 ms. T2 relaxation maps were
generated with ParaVision 6.0 (Bruker), from where the relaxation
times of the cell pellets were obtained.
5.7. Fluorescence and MRI of chick embryos in vivo
For injection into chick embryo brains, 2 × 105 cells, cultured un-
der the same conditions as described for iron uptake, were
suspended in saline containing deoxyribonuclease I (6 U/μL)
and Fast Green (2 mM). Fast Green is used as a guide for the in-
jection as it allows the monitoring of cell delivery at the site of
the injection, but is quickly cleared from the embryo. Fertilized
eggs of White Leghorn chicken were windowed at E3 as de-
scribed previously (38) and the cells were then injected into
the midbrain of embryos in ovo using a microcapillary pipette.
After receiving the cells, embryos were allowed to grow for a fur-
ther 48 h. Eggs were maintained at 38 °C and 40% humidity and
all animal work followed UK regulations (consolidated version of
ASPA 1986). At E5, embryos were removed from their eggs and
imaged using a Leica M165FC stereomicroscope. The embryos
were then fixed with 4% formaldehyde and mounted in 1.5 mL
tubes containing 1% low-melting agarose. Sagittal images of
the chick embryos were acquired using a high-resolution
TurboRARE T2-weighted sequence with the following parame-
ters: field of view 35 × 15 mm2, matrix size 597 × 256, slice thick-
ness 0.5 mm with no interslice gap, effective TE 39 ms, RARE
factor 8, TR 2990 ms, averages 3, flip angle 90°, scan time 4
min 47 s.
Acknowledgements
This work was supported by the Marie Curie EU Grant PERG08-
GA-2010-276909, UK EPSRC Grant EP/H046143 and the UK Re-
generative Medicine Platform (MR/K026739/1). Imaging data in
this article were obtained in the Centre for Preclinical Imaging
(CPI) of the University of Liverpool. The CPI has been part-funded
by Medical Research Council (MRC) Grant MR/L012707/1. The MR
scanner at the University of Manchester is supported by the UK
BBSRC (BB/F011350/1) and Karen Davies is thanked for its
management.
REFERENCES
1. Bhirde A, Xie J, Swierczewska M, Chen X. Nanoparticles for cell label-
ing. Nanoscale 2011; 3(1): 142–153.
2. Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J,
Baty R, Graziano EI, Proto Marco B, Caron A, Sköld P, Andrews PW,
Baxter MA, Hay DC, Hamdam J, Sharpe ME, Patel S, Jones DR,
Reinhardt J, Danen EHJ, Ben-David U, Stacey G, Björquist P, Piner J,
Mills J, Rowe C, Pellegrini G, Sethu S, Antoine DJ, Cross MJ, Murray
P, Williams DP,Kitteringham NR, Goldring CEP, Park BK. Concise
review: workshop review: understanding and assessing the risks of
stem cell-based therapies. Stem Cells Transl Med 2015; 4(4): 389–400.
3. James ML, Gambhir SS. A molecular imaging primer: modalities, im-
aging agents, and applications. Physiol Rev 2012; 92(2): 897–965.
4. Bulte JWM. In vivo MRI cell tracking: clinical studies. Am J Roentgenol
2009; 193(2): 314–325.
5. Richards JMJ, Shaw CA, Lang NN,Williams MC, Semple SIK,
MacGillivray TJ, Gray C, Crawford JH, Alam SR, Atkinson APM, Forrest
EK, Bienek C, Mills NL, Burdess A, Dhaliwal K, Simpson AJ, Wallace
WA, Hill AT, Roddie PH, McKillop G, Connolly TA, Feuerstein GZ,
Barclay GR, Turner ML, Newby DE. In vivo mononuclear cell tracking
using superparamagnetic particles of iron oxide: feasibility and
safety in humans. Circ Cardiovasc Imaging 2012; 5: 509–517
6. Ahrens ET, Zhong J. In vivo MRI cell tracking using perfluorocarbon
probes and fluorine-19 detection. NMR Biomed 2013; 26(7):
860–871.
7. Taylor A, Herrmann A, Moss D, Sée V, Davies K, Williams S, Murray P.
Assessing the efficacy of nano- and micro-sized magnetic particles
as contrast agents for MRI cell tracking. PLoS One 2014; 9
(6e100259).
8. Berman SC, Galpoththawela C, Gilad AA, Bulte JWM, Walczak P. Long-
term MR cell tracking of neural stem cells grafted in immunocompe-
tent versus immunodeficient mice reveals distinct differences in
contrast between live and dead cells. Magn Reson Med 2011; 65(2):
564–574.
9. Taylor A, Wilson KM, Murray P, Fernig DG, Levy R. Long-term tracking
of cells using inorganic nanoparticles as contrast agents: are we
there yet? Chem Soc Rev 2012; 41(7): 2707–2717.
10. Velde GV, Himmelreich U, Neeman M. Reporter gene approaches for
mapping cell fate decisions by MRI: promises and pitfalls. Contrast
Media Mol Imaging 2013; 8(6): 424–431.
11. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin
receptor gene expression by NMR imaging. Biochim Biophys Acta
1998; 1402(3): 239–249.
12. Koretsky A, Lin Y, Schorle H, Jaenische R. Genetic control of MRI con-
trast by expression of the transferrin receptor. In Proceedings of the
4th Annual Meeting of ISMRM. John Wiley & Sons: New Jersey, 1996;
5471.
13. Genove G, DeMarco U, Xu H, Goins W, Ahrens E. A new transgene re-
porter for in vivo magnetic resonance imaging. Nat Med 2005; 11
(43): 450–454.
14. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an en-
dogenous MRI reporter for noninvasive imaging of gene expression
in C6 glioma tumors. Neoplasia 2005; 7(2): 109117.
15. Wilkinson N, Pantopoulos K. The IRP/IRE system in vivo: insights from
mouse models. Front Pharmacol 2014; 5: 176.
16. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis
and the iron-responsive element/iron-regulatory protein (IRE/IRP)
regulatory network. Annu Rev Nutr 2008; 28: 197–213.
17. Pereira SM, Moss D, Williams SR, Murray P, Taylor A. Overexpression
of the MRI reporter genes ferritin and transferrin receptor affect iron
homeostasis and produce limited contrast in mesenchymal stem
cells. Int J Mol Sci 2015; 16(7): 15481.
18. Jayapal K, Wlaschin K, Hu W-S, Yap M. Recombinant protein thera-
peutics from CHO cells – 20 years and counting. Chem Eng Prog
2007; 103(10): 40–47.
19. Deans A, Wadghiri Y, Bernas L, Yu X, Rutt B, Turnbull DH. Cellular MRI
contrast via coexpression of transferrin receptor and ferritin. Magn
Reson Med 2006; 56(1): 51–59.
20. Iordanova B, Robison CS, Ahrens ET. Design and characterization of a
chimeric ferritin with enhanced iron loading and transverse NMR re-
laxation rate. J Biol Inorg Chem 2010; 15(6): 957–965.
21. Liu J, Cheng E, Long R, Wang Y, Cheng P, Yang J, Wu D, Mao H, Chan
A. Noninvasive monitoring of embryonic stem cells in vivo with MRI
transgene reporter. Tissue Eng C 2009; 15(4): 739–747.
S. M. PEREIRA ET AL.
wileyonlinelibrary.com/journal/cmmi Copyright © 2016 The Authors. Contrast Media & Molecular Imaging
published by John Wiley & Sons Ltd.
Contrast Media Mol. Imaging (2016)
22. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H,
Chiocca EA, Basilion JP. In vivomagnetic resonance imaging of trans-
gene expression. Nat Med 2000; 6(3): 351–355.
23. Boss A, Oppitz M, Wehrl HF, Rossi C, Feuerstein M, Claussen CD,
Drews U, Pichler BJ, Schick F. Measurement of T1, T2, and magnetiza-
tion transfer properties during embryonic development at 7 Tesla
using the chicken model. J Magn Reson Imaging 2008; 28(6): 1510–
1514.
24. Ford GC, Harrison PM, Rice DW, Smith JM, Treffry A, White JL, Yariv J.
Ferritin: design and formation of an iron-storage molecule. Phil Trans
R Soc London B 1984; 304(1121): 551–565.
25. Ponka P, Beaumont C, Richardson DR. Function and regulation of
transferrin and ferritin. Semin Hematol 1998; 35(1): 35–54.
26. Rouault TA. The role of iron regulatory proteins in mammalian iron
homeostasis and disease. Nat Chem Biol 2006; 2(8): 406–414.
27. Harrison PM, Arosio P. The ferritins: molecular properties, iron stor-
age function and cellular regulation. Biochim Biophys Acta 1996;
1275(3): 161–203.
28. Pourcelot E, Lénon M, Mobilia N, Cahn J-Y, Arnaud J, Fanchon E,
Moulis J-M, Mossuz P. Iron for proliferation of cell lines and hemato-
poietic progenitors: nailing down the intracellular functional iron
concentration. Biochim Biophys Acta 2015; 1853(7): 1596–1605.
29. Kakuta K, Orino K, Yamamoto S, Watanabe K. High levels of ferritin
and its iron in fetal bovine serum. Comp Biochem Physiol A 1997;
118(1): 165–169.
30. Kim HS, Cho HR, Choi SH, Woo JS, Moon WK. In vivo imaging of tu-
mor transduced with bimodal lentiviral vector encoding human fer-
ritin and green fluorescent protein on a 1.5T clinical magnetic
resonance scanner. Cancer Res 2010; 70(18): 7315–7324.
31. Choi SH, Cho HR, Kim HS, Kim YH, Kang KW, Kim H, Moon WK. Imag-
ing and quantification of metastatic melanoma cells in lymph nodes
with a ferritin MR reporter in living mice. NMR Biomed 2012; 25(5):
737–745.
32. Velde GV, Rangarajan JR, Toelen J, Dresselaers T, Ibrahimi A,
Krylychkina O, R. V, Van der Lindenv A, Maes F, Debyser Z,
Himmelreich U, Baekelandt V. Evaluation of the specificity and sensi-
tivity of ferritin as an MRI reporter gene in the mouse brain using
lentiviral and adeno-associated viral vectors. Gene Ther 2011; 18(6):
594–605.
33. Kim HS, Woo J, Lee JH, Joo HJ, Choi Y, Kim H, Moon WK, Kim SJ. In
vivo tracking of dendritic cell using MRI reporter gene, ferritin. PLoS
One 2015; 10(5e0125291).
34. Barrow M, Taylor A, Murray P, Rosseinsky MJ, Adams DJ. Design con-
siderations for the synthesis of polymer coated iron oxide nanopar-
ticles for stem cell labelling and tracking using MRI. Chem Soc Rev
2015; 44: 6733–6748.
35. Kutner R, Zhang X, Reiser J. Production, concentration and titration
of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 2009; 4:
495–505.
36. Bahr SM, Borgschulte T, Kayser KJ, Lin N. Using microarray technology to
select housekeeping genes in Chinese hamster ovary cells. Biotechnol
Bioeng 2009; 104(5): 1041–1046.
37. Lane DJR, Chikhani S, Richardson V, Richardson DR. Transferrin iron
uptake is stimulated by ascorbate via an intracellular reductive
mechanism. Biochim Biophys Acta 2013; 1833(6): 1527–1541.
38. Carter R, Mullassery D, See V, Theocharatos S, Pizer B, Losty PD,
Jesudason E, Moss DJ. Exploitation of chick embryo environments
to reprogram MYCN-amplified neuroblastoma cells to a benign phe-
notype, lacking detectable MYCN expression. Oncogenesis 2012; 1:
e24.
39. Kim HS, Woo J, Choi Y, Hwang EH, Choi SK, Cho K-W, Moon WK. Non-
invasive MRI and multilineage differentiation capability of ferritin-
transduced human mesenchymal stem cells. NMR Biomed 2015; 28
(2): 168–179.
SUPPORTING INFORMATION
Additional supporting information may be found in the online
version of this article at the publisher’s website.
EVALUATING THE EFFECTIVENESS OF TFR1 AS A MR REPORTER GENE
Contrast Media Mol. Imaging (2016) Copyright © 2016 The Authors. Contrast Media & Molecular Imaging
published by John Wiley & Sons Ltd.
wileyonlinelibrary.com/journal/cmmi
